Live Breaking News & Updates on Iontech

Stay informed with the latest breaking news from Iontech on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Iontech and stay connected to the pulse of your community

The company run by Ursula von der Leyen's husband produces anti-covid vaccines with European money

European Commission President Ursula von der Leyen said last week at the Global Gateway Forum in Brussels that she funded a 1.2 billion euro project through which BioNTech and Univercells built modular factories in Rwanda for the production of the vaccine with messenger RNA.

United-states , Ghana , Senegal , New-york , Germany , Budapest , Hungary , Belgium , Brussels , Bruxelles-capitale , Rwanda , South-africa

Global Gateway - the business of the von der Leyen family

Global Gateway, the European Union's euro300 billion global investment program, appears to be one in which the von der Leyens take the lion's share.

Rwanda , South-africa , Belgium , United-states , New-york , Ghana , Germany , Senegal , Budapest , Hungary , America , American

Combined COVID-flu vaccine from Pfizer, BioNTech moving to late-stage testing

Pfizer and BioNTech announced Thursday it would soon begin a Phase 3 trial for its combined flu and COVID-19 mRNA vaccine following “positive” results from its Phase 1/2 study. Phase 1 and 2 trials are meant to evaluate whether a new drug or treatment is both safe and effective. An official for Pfizer said Thursday…

Xavier-becerra , Annaliesa-anderson , Pfizer , Drug-administration , Human-services , Fast-track-designation , Human-services-secretary-xavier-becerra , Iontech , Rna-vaccine , Accine-research-and-development , Lu , Accine-uptake

BioNTech Climbs On Positive Data From BNT211 Trial

BioNTech SE (BNTX) shares are adding more than 4 percent on Tuesday morning trade after the company reported positive data for its first-in-human Phase 1/2 trial of Claudin-6, CAR-T cell therapy candidate BNT211 in patients with CLDN6-positive refractory/relapsed solid tumors.

Stock-alert , Iontech , Ntx ,

Covid-19 Could Trigger Guillain-Barré Syndrome, Study Finds

Researchers found a link between covid-19 and Guillain-Barré syndrome, while also finding that mRNA vaccination may lower the risk.

Israel , Haya-bishara , Sufjan-stevens , Lady-davis-carmel-medical-center , Pfizer , Roupb-streptococcal-infection , Treptococcus-agalactiae , Ealth , Edical , Harma , Accine , Ishara

BioNTech Turns to China Again for Cancer Drugs, Paying $70M to Partner on an ADC

BioNTech gains rights to a MediLink Therapeutics antibody drug conjugate that targets tumors expressing the HER3 protein. The deal comes six months after the German company entered the ADC field by acquiring rights to two therapeutic candidates from DualityBio.

China , Hong-kong , Suzhou , Jiangsu , Macau , Germany , German , Daiichi-sankyo , Daiichi-sankyo-enhertu , Astrazeneca , Medilink-therapeutics , China-based-medilink

Pfizer resolves Promosome patent lawsuit over COVID-19 vaccine

Pfizer, BioNTech and biotech firm Promosome told a federal judge in San Diego, California that they have agreed to end Promosome's lawsuit accusing the COVID-19 vaccine makers of infringing a patent related to messenger RNA technology. The companies said in a court filing on Wednesday that Promosome would dismiss its case with prejudice, which means it cannot be refiled, and that Promosome had agreed not to bring future claims over the patent against Pfizer and its partner BioNTech.

Washington , United-states , San-diego , California , Andrea-ricci , David-bario , Blake-brittain , Pfizer , Reuters , Us-patent-office , Scripps-research-institute-in-la-jolla , New-york-based-promosome

Nobel Prize awarded to pioneering mRNA scientists who helped develop COVID vaccines

The awarding of the Nobel Prize to Katalin Karikó and Drew Weissman is justly deserved and has all the more significance in that it takes place under conditions of a vast right-wing anti-science campaign.

Hungary , China , Australia , Germany , Russia , Rome , Lazio , Italy , United-states , Wuhan , Hubei , Switzerland

Kariko and Weissman win medicine Nobel for COVID-19 vaccine work

STOCKHOLM (Reuters) -Hungarian scientist Katalin Kariko and U.S. colleague Drew Weissman, who met in line for a photocopier before making mRNA molecule discoveries that paved the way for COVID-19 vaccines, won the 2023 Nobel Prize for Medicine on Monday. The prize, among the most prestigious in the scientific world, was selected by the Nobel Assembly of Sweden's Karolinska Institute medical university and comes with 11 million Swedish crowns (about $1 million) to share between them. Kariko, a former senior vice president and head of RNA protein replacement at German biotech firm BioNTech, is a professor at the University of Szeged in Hungary and adjunct professor at the University of Pennsylvania.

Stockholm , Sweden , Oslo , Norway , Swedish , Swede , Alfred-nobel , Terje-solsvik , Andrew-cawthorne , Svante-paabo , Ludwig-burger , Karl-landsteiner

Scientists whose work on mRNA paved the way for first COVID-19 vaccines win Nobel Prize

Nobel Prize winners Katalin Karikó and Drew Weissman harnessed messenger RNA, an advance that led to the Pfizer and Moderna COVID-19 vaccines.

University-of-pennsylvania , Pennsylvania , United-states , Szeged , Hungary , South-africa , Philadelphia , Thailand , Temple-university , Bethesda , Germany , China